Amiodarone
FDA Approved
Contents
Description
Amiodarone is a Class III antiarrhythmic agent used for life-threatening ventricular arrhythmias. It is particularly useful in arrhythmogenic ventricular dysplasia and other structural heart diseases with arrhythmias. The drug has multiple mechanisms including potassium channel blockade and beta-blocking effects.
Indications & Therapeutic Use
ventricular tachycardia, ventricular fibrillation, atrial fibrillation, arrhythmogenic ventricular dysplasia
Global Availability (9 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Amiodarone — GNH India
205 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
AMIODA-POWER Injection
150mg/3mlampoulesIndia
Amiodar
EU
Amiodaron 1 A Pharma
EU
Amiodaron Aurobindo
EU
Amiodaron Evolan
EU
Amiodaron Hameln
EU
Amiodaron Hcl Aurobindo
EU
Amiodaron Hcl Hikma
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Amiodarone
| Generic Name | amiodarone |
| Brands | 1 brand available |
| Active Ingredient | amiodarone hydrochloride |
| Drug Class | ventricular tachycardia |
| Manufacturer | Sanofi |
| Dosage Forms | oral tablet 100mg, 200mg, 400mg; IV infusion 50mg/mL |
| Medical Code | C01BD01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00000556 |
| Countries | 9 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations10 Validated Nodes